Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
Vectus Biosystems Limited is an Australian clinical-stage biotechnology company listed on the ASX under the code VBS. Its address is Unit 5, Ground Floor, 26-34 Dunning Avenue, Rosebery, New South Wales. Dr Ronald Shnier is Chairman, and Dr Tara Speranza serves as Chief Executive …
Vitasora Health Limited is listed on the Australian Securities Exchange under the code VHL, and its shares also trade on the OTCQB under the code VHLUF. The company is headquartered in Melbourne, Victoria, with offices in Los Angeles. Marjan Mikel is CEO and Managing …
Acrux Limited is a specialty pharma company listed on the ASX under the code ACR, with offices at 103-113 Stanley Street, West Melbourne, Victoria. Drawing on 25 years of experience, it has marketed a number of products worldwide through licensees, with an emphasis on …
AVITA Medical, Inc. is listed on NASDAQ under the ticker RCEL and on the Australian Securities Exchange under the ticker AVH. The company is headquartered in Valencia, California, and describes itself as a therapeutic acute wound care company delivering solutions designed to optimise wound …
Careteq Limited is listed on the Australian Securities Exchange under the code CTQ and has its office at Level 10, 99 Queen Street, Melbourne. It describes itself as an Australian healthtech company focused on solutions for the home care and disability sector.
Emyria Limited is listed on the Australian Securities Exchange under the code EMD and its shares are also admitted to trade on the Frankfurt Open Market under the code Q84. The registered office is in Subiaco, Western Australia.
Noxopharm Limited is an Australian clinical-stage biotechnology company listed on the Australian Securities Exchange under the code NOX. Its address is Suite 71, 159 Ridgecrop Drive, Castle Hill, New South Wales. Dr Olivier Laczka is the Chief Executive Officer.
Nexsen Limited is listed on the ASX under the code NXN and operates from Suite 1005, 4 Bridge Street, Sydney, New South Wales. The company develops a growing portfolio of rapid point-of-care diagnostics for serious conditions where delays in diagnosis can affect patient outcomes …
Prescient Therapeutics is headquartered in Melbourne, Australia, and trades on the ASX under the ticker PTX. The company describes itself as a clinical-stage oncology company developing personalised cancer treatments through targeted therapies and advanced cell therapy enhancement platforms. James McDonnell is Chief Executive Officer, …
Healthcare companies are affected by patient volumes, government funding and reimbursement settings, product demand, regulation andAcquisitionintegration. The releases refer to plasma market conditions, hospital funding arrangements and pharmacy demand, includingDemandfor GLP-1 medicines.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…